NEW YORK (GenomeWeb News) – The Fox Chase Cancer Center in Philadelphia has launched the Institute for Personalized Medicine, which will use the center's sample repository and oncology programs along with sequencing to develop personalized chemotherapy approaches.
The IPM will use the center's biosample repository and tumor bank to develop genetic information about individual tumors, and it will incorporate this type of data in its Phase I Clinical Trials Program.